_
News Releases
Upcoming Appearances
Past Appearances
Publications
News Releases

May 5, 2014 - Press Release
Cenix BioScience signs research service agreement with Bayer Pharma AG
Jan 7, 2014 - News Item
Cenix joins new EU FP7 atherosclerosis therapy initiative
Aug 7, 2013 - News Item
Cenix joins EU FP7 program for discovery of miRNA medicines
May 23, 2013 - Press Release
Cenix BioScience and Debiopharm Group collaborate to identify predictive biomarkers
Oct 4, 2012 - Press Release
ugichem extends scope of contract research with Cenix BioScience
Sep 20, 2012 - Press Release
Children's Tumor Foundation and Cenix BioScience sign framework research agreement
Mar 1, 2012 - Press Release
Cenix BioScience expands operations to U.S.
Dec 12, 2011 - Press Release
CYTOO, Cenix BioScience and academic collaborators launch EU FP7 MEHTRICS consortium
Nov 17, 2011 - Press Release
Cenix signs RNAi research agreement with SYGNIS
Aug 31, 2011 - Press Release
Cenix BioScience and ugichem sign research agreement on development of novel gene silencing technology
May 4, 2011 - Press Release
Cenix BioScience Signs Collaboration and Technology License Agreement for In Vivo siRNA Delivery
Mar 25, 2011 - Press Release
Cenix BioScience joins EU FP7 consortium to advance in vivo use of siRNAs in respiratory and inflammation areas
Mar 16, 2011 - News Item
Cenix congratulates co-founder Prof. Tony Hyman for being awarded the 2011 Leibniz Prize!
Jan 11, 2011 - Press Release
Cenix BioScience grows, establishing new R&D subsidiary in Flanders, Belgium
Dec 13, 2010 - News Item
Cenix BioScience awarded major R&D grant for further development of its in vivo RNAi platform
Nov 11, 2010 - News Item
Cenix BioScience and Integromics awarded EU FP7 EuroTransBio grant to co-develop integrated data analysis environment for HT-RNAi screening
Oct 26, 2009 - News Item
Cenix BioScience celebrates 10th anniversary
Jun 15, 2009 - Press Release
Cenix BioScience expands relationship with AstraZeneca, signing multi-project research agreement
Mar 19, 2009 - Press Release
Cenix BioScience follows up successful RNAi-based target discovery screens with target validation study for AstraZeneca.
Feb 2, 2009 - Press Release
Cenix BioScience Signs Research Agreement with Boehringer Ingelheim for RNAi-Based Target Discovery
Nov 17, 2008 - Press Release
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
Nov 11, 2008 - Press Release
IMM, Cenix and Alnylam Discover New Targets in Malaria Infection with RNAi Technology
Nov 3, 2008 - News Item
Cenix BioScience joins EU FP7 grant-funded consortium to identify markers for personalized medication in complex diseases
Sep 11, 2008 - Press Release
Instituto de Medicina Molecular, Cenix BioScience, and Alnylam Pharmaceuticals discover new pathway for malaria infection
Aug 6, 2008 - News Item
Cenix BioScience awarded grant from German state of Saxony for development of an in vivo RNAi platform
Jul 21, 2008 - Press Release
Cenix BioScience Signs Research Agreement with Regulus Therapeutics for miRNA-Targeted Drug Discovery
Jul 1, 2008 - Press Release
Following success of pilot, Cenix BioScience takes on second RNAi-Based Target Validation project for CellCentric
Apr 2, 2008 - News Item
Cenix BioScience and collaborators awarded major research grant from German National Genome Research Network (NGFN) for development of anti-malarial agents
Mar 20, 2008 - Press Release
Cenix BioScience and CellCentric Sign Framework Research Agreement for RNAi-Based Target Validation
Mar 19, 2008 - Press Release
Cenix BioScience Signs Framework Research Agreement with AstraZeneca for RNAi-Based Drug Discovery
Feb 12, 2008 - Press Release
Cenix BioScience Expands Usage of Definiens Technology in High-Content Screening
Feb 12, 2008 - Press Release
Biotechnology Leader Speeds Research With TIBCO Spotfire Enterprise Analytics Platform
Nov 5, 2007 - News Item
Cenix BioScience joins NANOTOME consortium, securing grant support from German Federal Ministry of Education and Research (BMBF)
Jan 30, 2007 - Press Release
Siena Biotech commissions Cenix BioScience to carry out HT-RNAi discovery project on neurodegenerative disease
Oct 23, 2006 - Press Release
Cenix BioScience, Applied Biosystems and Dresden University to create a New Facility for Proteomics Profiling of RNAi and Drug Effects in Human Cells
English | German
Sep 27, 2006 - Press Release
Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
Jul 3, 2006 - News Item
Cenix BioScience awarded INNO-WATT grant from German Federal Ministry of Economics and Technology (BMWi) for development of novel anti-malarial treatments
Oct 25, 2005 - Press Release
Following Success of Pilot, Cenix BioScience and Schering AG enter into Agreement on Multiple RNAi-based Target Validation Projects
Aug 9, 2005 - Press Release
Cenix BioScience Delivers on Target Discovery Collaboration as Bayer HealthCare AG Acquires Potential Novel Therapeutic Targets Identified by RNAi Screening
Jul 12, 2005 - Press Release
Hunt for human genes involved in cell division under way: EMBL starts screening genome-wide siRNA library in EU project MitoCheck
Jun 29, 2005 - Press Release
Cenix BioScience and The Instituto de Medicina Molecular Initiate First Genome-Scale RNAi Screen for Novel Malaria Genes
May 9, 2005 - Press Release
Definiens and Cenix BioScience Enter into Licensing and Co-Marketing Agreement in High-Content Screening
Mar 24, 2005 - Press Release
Cenix BioScience Publishes Comprehensive Genome-Wide RNAi Screen of C. elegans Cell Division Genes and Releases Full Dataset Online
Feb 28, 2005 - Press Release
Cenix BioScience and Schering AG Sign Research Agreements to Advance Several Disease Programs
Jan 6, 2005 - News Item
Cenix BioScience and collaborators secure major German National Genome Research Network (NGFN) consortium grant for RNAi platform development
Aug 2, 2004 - News Item
Cenix BioScience and collaborators awarded research grant under InnoRegio program of German Federal Ministry of Education and Research (BMBF) for diversification of RNAi technologies
Aug 2, 2004 - Press Release
Ambion and Cenix release the Drosophila RNAi library, fulfilling the broadest RNAi library product line available
May 11, 2004 - Press Release
Cenix BioScience moves into new, state of the art facilities in Dresden's BioInnovation Center
Jan 27, 2004 - Press Release
Cenix BioScience announces appointment of Zisi Fotev as new Chief Business Officer
Jan 13, 2004 - Press Release
Alnylam and Cenix BioScience enter into research alliance and licensing agreement in RNA interference
Dec 15, 2003 - Press Release
Cenix BioScience Announces Collaboration with Bayer HealthCare AG to Discover and Validate Novel Therapeutic Targets using Genomic High Throughput RNAi in Human Cells
Oct 17, 2003 - Press Release
Cenix co-founder Anthony Hyman receives EMBO Gold Medal 2003
Sep 24, 2003 - Press Release
Dr. Christophe Echeverri named one of the world's top young innovators by Technology Review, MIT's magazine of innovation
Aug 26, 2003 - Press Release
Ambion and Cenix BioScience announce availability of pre-designed siRNAs covering the human, mouse and rat genomes
English | German
Mar 24, 2003 - Press Release
Ambion and Cenix BioScience partner to offer first commercially-available human genome-wide siRNA library
English | German
Sep 10, 2002 - Press Release
Cenix BioScience raises &euro 5 million in international financing round
English | German
Jul 2, 2001 - News Item
Cenix BioScience awarded major research grant under InnoRegio program of German Federal Ministry of Education and Research for RNAi-based development of anti-cancer drugs
Jun 4, 2001 - News Item
Cenix BioScience and collaborators secure research grant from German National Genome Research Network (NGFN) to advance RNAi-based phenotyping
Jun 5, 2000 - News Item
Cenix BioScience and collaborators awarded major research grant from German Federal Ministry of Education and Research (BMBF) for RNAi screening in C. elegans

top of page
© Cenix BioScience GmbH 2014. All rights reserved.